Staying at a lower dose might be the right move if: You are still experiencing good appetite suppression
Most postpartum women notice significant appetite changes within the first 3 to 4 weeks, with meaningful weight reduction becoming visible by week 8 to 12
Sources FDA FDA Approves New Medication for Chronic Weight Management FDA Wegovy Prescribing Information New England Journal of Medicine Once-Weekly Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Tirzepatide Once Weekly for the Treatment of Obesity CDC Adult Obesity Facts NIDDK Definition & Facts for Adult Overweight & Obesity World Health Organization Obesity: GLP-1 Therapies
Because rapid weight loss on GLP-1 agonists includes lean-mass loss, the documented supportive measures are: Adequate dietary protein to help preserve muscle during a caloric deficit
The perception that excess weight is an aesthetic problem instead of a public health problem is still rife, according to Professor Julia Goedecke from the South African Medical Research Council (SAMRC)
It works similarly to GLP-1 by regulating glucose levels and encouraging weight loss, which makes it a successful type 2 diabetes and obesity treatment
